The White House is considering launching a new prescription drug website potentially branded as "TrumpRx," aimed at helping patients find discounted medications directly from pharmaceutical manufacturers. The initiative aligns with former President Donald Trump's ongoing campaign to reduce drug prices in the United States to levels comparable to those paid in other developed countries. According to Bloomberg News, the platform would allow users to search for specific prescription drugs and connect with vendors offering those medicines at lower costs.
This potential website comes amid broader efforts by the Trump administration to increase transparency and accuracy in prescription drug advertising. In September 2025, President Trump signed a Presidential Memorandum directing federal agencies to crack down on misleading direct-to-consumer pharma ads, including those on social media and other digital platforms. The administration plans to enforce existing regulations more strictly and issue cease-and-desist letters to companies violating advertising rules.
Trump has also pushed for most-favored-nation (MFN) pricing policies, which would require drug manufacturers to lower prices to match the lowest prices offered in other developed countries. The proposed website could support these goals by enabling Americans to purchase prescription medicines more affordably without intermediaries, potentially bypassing middlemen to reduce costs.
While the White House and related departments have not publicly confirmed the launch or formal name of the site, insiders say "TrumpRx" is a leading candidate. The effort reflects Trump’s promise to put American patients first, reduce pharmaceutical price burdens, and increase competition and transparency in the drug market.
If realized, "TrumpRx" could become a significant tool in the federal government’s broader strategy to lower drug prices and provide consumers with better access to vital medications at fair prices, revolutionizing how prescription drugs are purchased and advertised in the U.S. healthcare system.
- https://www.reuters.com/business/healthcare-pharmaceuticals/us-weighs-trump-branded-website-help-shop-cheaper-drugs-bloomberg-news-reports-2025-09-19/
- https://www.whitehouse.gov/fact-sheets/2025/09/fact-sheet-president-donald-j-trump-announces-actions-to-provide-greater-transparency-and-accuracy-in-prescription-drug-advertisements/
- https://www.bloomberg.com/news/articles/2025-09-19/us-weighs-trump-branded-website-to-help-shop-for-cheaper-drugs
- https://www.cnbc.com/2025/09/09/trump-signs-memo-to-crack-down-on-direct-to-consumer-pharma-ads.html
- https://www.whitehouse.gov/fact-sheets/2025/07/fact-sheet-president-donald-j-trump-announces-actions-to-get-americans-the-best-prices-in-the-world-for-prescription-drugs/
- https://www.whitehouse.gov/presidential-actions/2025/09/memorandum-for-the-secretary-of-health-and-human-services-the-commissioner-of-food-and-drugs/
- https://www.congress.gov/crs-product/LSB11319
- https://www.hhs.gov/press-room/hhs-prescription-drug-price-transparency-rule.html
- https://www.federalregister.gov/documents/2025/04/18/2025-06837/lowering-drug-prices-by-once-again-putting-americans-first
- https://www.whitehouse.gov/presidential-actions/2025/05/delivering-most-favored-nation-prescription-drug-pricing-to-american-patients/
Comments
0 comment